Terms: = Germ cell tumor AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Diagnosis
46 results:
1. Update on Selected High-grade Renal cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract] [Full Text] [Related]
2. Advanced fumarate hydratase-deficient renal cell carcinoma responding to combination immune checkpoint inhibitors.
Howells E; Wigston L; Mackie G; Tran B; Nott L
Can J Urol; 2023 Jun; 30(3):11558-11561. PubMed ID: 37344468
[TBL] [Abstract] [Full Text] [Related]
3. [Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases].
Wang XX; Liu Y; Liu LC; Wang YX; Yang J; Hu AJ; Zhang B; Liu CR
Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):574-579. PubMed ID: 37263921
[No Abstract] [Full Text] [Related]
4. Metabolomics in paraganglioma: applications and perspectives from genetics to therapy.
Richter S; Garrett TJ; Bechmann N; Clifton-Bligh RJ; Ghayee HK
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36897220
[TBL] [Abstract] [Full Text] [Related]
5. Case Report of Dermoscopic Aspects and Reflectance Confocal Microscopy Description of Segmental Leiomyoma and Relative Management.
Paolino G; Pampena R; Rizzo N; Di Nicola MR; Mercuri SR
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557047
[TBL] [Abstract] [Full Text] [Related]
6. Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
[TBL] [Abstract] [Full Text] [Related]
7. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
8. germline Whole-Gene Deletion of FH Diagnosed from tumor Profiling.
Ueki A; Sugano K; Misu K; Aimono E; Nakamura K; Tanishima S; Tanaka N; Mikami S; Hirasawa A; Ando M; Yoshida T; Oya M; Nishihara H; Kosaki K
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360727
[TBL] [Abstract] [Full Text] [Related]
9. Genetics of pheochromocytoma and paraganglioma.
Wachtel H; Fishbein L
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
[TBL] [Abstract] [Full Text] [Related]
10. CT diagnosis of ilioinguinal lymph node metastases in melanoma using radiological characteristics beyond size and asymmetry.
Wilkinson MJ; Snow H; Downey K; Thomas K; Riddell A; Francis N; Strauss DC; Hayes AJ; Smith MJF; Messiou C
BJS Open; 2021 Jan; 5(1):. PubMed ID: 33609385
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C
Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023
[TBL] [Abstract] [Full Text] [Related]
12. An update on adult forms of hereditary pheochromocytomas and paragangliomas.
Dariane C; Goncalves J; Timsit MO; Favier J
Curr Opin Oncol; 2021 Jan; 33(1):23-32. PubMed ID: 33186184
[TBL] [Abstract] [Full Text] [Related]
13. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.
Nantavithya C; Paulino AC; Liao K; McGovern SL; Grosshans DR; McAleer MF; Woodhouse KD; Khatua S; Chintagumpala MM; Majd NK; Yeboa DN
Pediatr Blood Cancer; 2020 Aug; 67(8):e28373. PubMed ID: 32453481
[TBL] [Abstract] [Full Text] [Related]
14. [Hereditary kidney cancers: The pathologist's view in 2020].
Verkarre V; Morini A; Denize T; Ferlicot S; Richard S
Ann Pathol; 2020 Apr; 40(2):148-167. PubMed ID: 32197858
[TBL] [Abstract] [Full Text] [Related]
15. [A special uterine leiomyoma].
Brunet A; Verkarre V; Le Frère Belda MA
Ann Pathol; 2020 Apr; 40(2):180-184. PubMed ID: 32192807
[TBL] [Abstract] [Full Text] [Related]
16. [Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma].
Broudin C; Favier J; Verkarre V; Méatchi T
Ann Pathol; 2020 Apr; 40(2):134-141. PubMed ID: 32146049
[TBL] [Abstract] [Full Text] [Related]
17. Metabolomics in the diagnosis of Pheochromocytoma and Paraganglioma.
Dwight T; Kim E; Novos T; Clifton-Bligh RJ
Horm Metab Res; 2019 Jul; 51(7):443-450. PubMed ID: 31307108
[TBL] [Abstract] [Full Text] [Related]
18. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract] [Full Text] [Related]
19. Prospective Detection of germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal cell Carcinoma Syndrome: A 5-Year Single Institutional Experience.
Rabban JT; Chan E; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757
[TBL] [Abstract] [Full Text] [Related]
20. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
[TBL] [Abstract] [Full Text] [Related]
[Next]
